Alzheon

Alzheon, Inc. is a privately held clinical-stage biopharmaceutical company founded in 2013 and headquartered at 111 Speen Street, Framingham, Massachusetts, developing oral small-molecule therapeutics and diagnostics for Alzheimer's disease and other neurodegenerative disorders. Its lead candidate, valiltramiprosate (ALZ-801) — a valine-conjugated prodrug of tramiprosate that blocks the formation of neurotoxic soluble beta-amyloid oligomers — has FDA Fast Track designation and completed the pivotal APOLLOE4 Phase 3 trial in APOE4/4 homozygotes with early Alzheimer's disease. Alzheon operates no product or developer API and publishes no developer portal, SDKs or API documentation; its corporate site does serve the standard WordPress REST API anonymously, which makes its press releases, science pages and media library machine-readable.

Alzheon publishes 1 API on the APIs.io network: Content API (WordPress REST). Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Clinical Trials.

Alzheon’s developer surface includes engineering blog, product news, and 15 more developer resources.

26.2/100 emerging ▬ flat Agent 21/100 agent aware Full breakdown ↓
scored 2026-08-05 · rubric v0.9.1
1 APIs
CompanyBiotechnologyPharmaceuticalsLife SciencesClinical TrialsAlzheimer's DiseaseNeurologyDrug DevelopmentHealthcarePrivate Company

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-05 · rubric v0.9.1
Composite quality — 26.2/100 · emerging
Contract Quality 15.7 / 25
Developer Ergonomics 0.8 / 20
Commercial Clarity 2.1 / 20
Operational Transparency 0.0 / 13
Governance 1.4 / 12
Discoverability 8.7 / 10
Agent readiness — 21/100 · agent aware
Machine-Readable Contract 18 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 5 / 5
Well-Known Catalog 4 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/alzheon: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

APIs 1

Individual APIs this provider publishes, each with its own machine-readable definition.

Alzheon Content API (WordPress REST)

Read-only, anonymously accessible WordPress REST API served by the Alzheon corporate site at https://alzheon.com/wp-json. It exposes the company's press releases and in-the-news...

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Alzheon Authentication

http · 1 scheme

SECURITY

Alzheon Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Agent Surfaces 3

MCP servers, agent skills, and machine-readable catalogs

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 1

Pricing, plans, and the legal terms of use

Company 8

The organization behind the API

Scroll for all 8

Other 3

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: alzheon
name: Alzheon
description: Alzheon, Inc. is a privately held clinical-stage biopharmaceutical company founded in 2013 and headquartered
  at 111 Speen Street, Framingham, Massachusetts, developing oral small-molecule therapeutics and diagnostics for Alzheimer's
  disease and other neurodegenerative disorders. Its lead candidate, valiltramiprosate (ALZ-801) — a valine-conjugated prodrug
  of tramiprosate that blocks the formation of neurotoxic soluble beta-amyloid oligomers — has FDA Fast Track designation
  and completed the pivotal APOLLOE4 Phase 3 trial in APOE4/4 homozygotes with early Alzheimer's disease. Alzheon operates
  no product or developer API and publishes no developer portal, SDKs or API documentation; its corporate site does serve
  the standard WordPress REST API anonymously, which makes its press releases, science pages and media library machine-readable.
url: https://raw.githubusercontent.com/api-evangelist/alzheon/refs/heads/main/apis.yml
image: https://alzheon.com/wp-content/uploads/2016/03/alzheon-logo2.svg
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment-pipeline-2026-07-31
x-sector: biotechnology
x-api-posture: no-product-api
specificationVersion: '0.20'
created: '2026-07-31'
modified: '2026-07-31'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Clinical Trials
- Alzheimer's Disease
- Neurology
- Drug Development
- Healthcare
- Private Company
apis:
- name: Alzheon Content API (WordPress REST)
  description: 'Read-only, anonymously accessible WordPress REST API served by the Alzheon corporate site at https://alzheon.com/wp-json.
    It exposes the company''s press releases and in-the-news items (224 posts), static science / pipeline / people / patients
    pages (25), the media library (624 items), taxonomies, cross-content search and oEmbed. This is an incidental content
    management surface, not a first-party API product: Alzheon publishes no developer documentation, keys, SDKs, support channel
    or terms of use for it, and all administrative and write routes return 401 to anonymous callers.'
  humanURL: https://alzheon.com/media/press-releases/
  baseURL: https://alzheon.com/wp-json
  tags:
  - Content
  - Press Releases
  - WordPress
  - CMS
  properties:
  - type: OpenAPI
    url: openapi/alzheon-content-openapi.yml
  - type: Overlay
    url: overlays/alzheon-content-overlay.yaml
  - type: Authentication
    url: authentication/alzheon-authentication.yml
  - type: Conventions
    url: conventions/alzheon-conventions.yml
  - type: ErrorCatalog
    url: errors/alzheon-problem-types.yml
  - type: DataModel
    url: data-model/alzheon-data-model.yml
  - type: Lifecycle
    url: lifecycle/alzheon-lifecycle.yml
  - type: Conformance
    url: conformance/alzheon-conformance.yml
  - type: AgentSkill
    url: skills/_index.yml
  - type: BlogRSS
    url: https://alzheon.com/feed/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://alzheon.com/
- type: Blog
  url: https://alzheon.com/media/press-releases/
- type: BlogRSS
  url: https://alzheon.com/feed/
- type: News
  url: https://alzheon.com/media/in-the-news/
- type: PrivacyPolicy
  url: https://alzheon.com/privacy-policy/
- type: Contact
  url: https://alzheon.com/contact/
- type: Careers
  url: https://alzheon.com/careers/
- type: About
  url: https://alzheon.com/people/about-us/
- type: Pipeline
  url: https://alzheon.com/science/pipeline/
- type: Publications
  url: https://alzheon.com/science/publications/
- type: LinkedIn
  url: https://www.linkedin.com/company/alzheon
- type: Twitter
  url: https://x.com/Alzheon
- type: SecondaryMarket
  url: https://forgeglobal.com/alzheon_stock/
- type: WellKnown
  url: well-known/alzheon-well-known.yml
- type: DomainSecurity
  url: security/alzheon-domain-security.yml
- type: AgentSkill
  url: skills/_index.yml
- type: LLMsTxt
  url: llms/alzheon-llms.txt
x-enrichment:
  date: '2026-07-31'
  status: enriched
  artifacts_added: 14
  pass: local-v1
  notes: No product API. Contract discovery probed alzheon.com and www.alzheon.com plus seven non-resolving subdomains for
    OpenAPI, GraphQL, MCP tools/list, A2A agent cards and the full /.well-known/ set — all 404 or NXDOMAIN. The one real machine-readable
    contract found is the site's anonymous WordPress REST API at https://alzheon.com/wp-json (15 namespaces, 311 routes);
    an OpenAPI 3.1 covering 24 verified anonymous read operations was derived from that live route index. No packages, MCP
    server, agent card, OAuth scopes, vulnerability-disclosure programme or trust center exist; those artifacts were deliberately
    not written rather than stubbed.